From MSO asset purchases to SBA-backed earnouts, learn the deal structures that protect buyers and close sellers in the $1M–$5M behavioral health market.
Acquiring a behavioral health practice requires deal structures that address challenges you simply won't encounter in a standard business acquisition. Corporate practice of medicine laws in many states prohibit non-clinician entities from directly owning a clinical practice, forcing buyers to use Management Services Organization (MSO) structures that bifurcate the management layer from the licensed clinical entity. On top of that, therapist retention, payer credentialing continuity, and key-person risk tied to an owner-clinician all introduce post-closing revenue uncertainty that must be priced into the deal terms. The most successful behavioral health acquisitions use a layered deal structure that combines a clearly defined purchase price, seller financing or equity rollover, and performance-based earnouts anchored to patient census and clinician headcount — the two variables most likely to determine whether revenue holds after the ownership transition. Whether you are a private equity-backed behavioral health platform acquiring a regional group practice or a clinician operator buying your first outpatient clinic with SBA financing, understanding the mechanics of each available deal structure is the starting point for a successful transaction.
Find Behavioral Health Practice Businesses For SaleAsset Purchase with MSO Structure
The buyer acquires the non-clinical assets of the practice — including goodwill, contracts, equipment, EHR systems, and billing infrastructure — through a Management Services Organization entity that provides administrative services to a newly formed or acquired professional entity (PC or PLLC) owned by a licensed clinician. This structure is the dominant approach in states with corporate practice of medicine (CPOM) restrictions, including California, New York, Texas, and Illinois. The MSO holds the economic value of the business while the professional entity retains the clinical licensure and payer contracts.
Pros
Cons
Best for: Private equity-backed behavioral health platforms, physician practice management companies, or non-clinician operators acquiring practices in CPOM states where direct ownership of a clinical entity is prohibited.
Stock Purchase with Earnout
The buyer acquires 100% of the equity in the existing professional corporation or PLLC, assuming all assets and liabilities. An earnout provision ties a portion of the purchase price — typically 15–30% — to post-closing performance metrics such as patient census retention at 12 and 24 months, licensed clinician headcount, or revenue from maintained insurance contracts. This structure is most common when the seller wants maximum upfront value and the buyer needs protection against post-closing patient attrition or staffing disruption.
Pros
Cons
Best for: Strategic acquirers and regional group practice operators in non-CPOM states acquiring established practices with diversified clinician rosters and verified payer contracts, where revenue continuity is the primary acquisition thesis.
SBA 7(a) Asset Acquisition with Seller Equity Rollover
An SBA 7(a) loan finances 80–90% of the purchase price in an asset acquisition, with the seller rolling 10–20% of the transaction value back into the business as a subordinated equity stake or seller note that satisfies SBA injection requirements. The seller typically signs a 2-year employment or consulting agreement as part of the transition plan, which is required by SBA lenders to demonstrate clinical continuity and protect against key-person revenue collapse. This structure is the primary pathway for individual clinicians and first-time healthcare operators entering the behavioral health acquisition market.
Pros
Cons
Best for: Individual clinicians, licensed clinical operators, or first-time healthcare buyers acquiring an outpatient therapy or group practice with $1M–$3M in revenue where seller financing combined with SBA leverage enables ownership with limited upfront equity.
Private Equity Platform Acquires Outpatient Group Practice in a CPOM State
$3,200,000
$2,240,000 (70%) paid in cash at closing through the MSO asset purchase; $640,000 (20%) seller note at 6% interest over 3 years subordinated to senior debt; $320,000 (10%) earnout payable over 24 months tied to maintaining minimum 85% of trailing 12-month patient census and retaining at least 6 of 8 licensed clinicians at month 12 and month 24 milestones.
Asset purchase structured through a newly formed MSO; seller retains nominal ownership of the professional PC under a management services agreement; seller signs 18-month clinical transition and non-compete agreement covering a 25-mile radius for 3 years; earnout measured quarterly with buyer audit rights on EHR session data and billing reports; payer re-credentialing initiated at letter of intent stage to minimize revenue gap.
SBA 7(a) Acquisition of Outpatient Therapy Practice by First-Time Buyer
$1,800,000
$1,440,000 (80%) financed through SBA 7(a) loan at 10-year amortization; $270,000 (15%) seller note subordinated to SBA debt, structured as a 5-year note at 5.5% interest satisfying SBA equity injection requirement; $90,000 (5%) buyer cash equity injection at closing.
Asset purchase excluding accounts receivable, which seller collects post-closing under a 90-day collection agreement; seller signs 24-month part-time employment agreement at $85,000 annually to maintain payer credentialing continuity and introduce buyer to key referral sources; non-solicitation agreement covering all current clinicians and patients for 3 years; SBA lender requires seller attestation of clean HIPAA compliance and no outstanding insurance audits as a loan condition.
Stock Purchase with Earnout — Regional Platform Expanding into New Market
$4,500,000
$3,150,000 (70%) cash at closing via stock purchase agreement; $900,000 (20%) earnout payable in two equal tranches at month 12 and month 24 tied to maintaining revenue at or above 90% of the prior 12-month trailing revenue and retaining minimum 10 licensed clinicians on staff; $450,000 (10%) seller equity rollover into the acquiring platform entity at negotiated equity value.
Full entity stock purchase including assumption of all insurance contracts, EHR systems, and existing lease obligations; buyer purchases a representations and warranties insurance policy covering pre-closing HIPAA, billing, and employment liabilities up to $2,000,000; seller transitions to non-clinical Director of Clinical Partnerships role for 24 months at $120,000 annually to maintain referral source relationships; earnout calculated from EHR-verified session revenue and payroll records submitted quarterly.
Find Behavioral Health Practice Businesses For Sale
Pre-screened targets ready for your deal structure — free to join.
In states with corporate practice of medicine (CPOM) laws — which include California, New York, Texas, Illinois, and more than a dozen others — it is legally prohibited for non-licensed entities to directly own or control a clinical medical or mental health practice. Since most buyers, including private equity firms, strategic operators, and non-clinician individuals, are not licensed clinicians, they cannot directly own the professional entity that holds the therapy licenses and employs the clinicians. The MSO structure resolves this by creating two entities: a professional corporation (PC) or PLLC nominally owned by a licensed clinician that holds all clinical operations, and a Management Services Organization owned by the buyer that provides all non-clinical services — billing, HR, facilities, marketing, and administration — in exchange for a management fee that captures the economic value of the business. This structure is standard in behavioral health and is well-understood by experienced healthcare M&A attorneys and SBA lenders, but it does add legal complexity and cost to the transaction.
Behavioral health earnouts most commonly tie payments to patient census retention and licensed clinician headcount rather than revenue or EBITDA, because those are the two variables most directly under the seller's influence during the transition period. A typical structure pays 50% of the earnout at the 12-month mark if patient census is at or above 85–90% of the pre-closing baseline, and the remaining 50% at 24 months subject to the same thresholds. To avoid disputes, the earnout agreement must specify exactly how patient census is measured — active patients with a session in the prior 60 days is a common definition — and designate the EHR system as the authoritative data source. The agreement should also define what happens when patients leave for reasons outside the seller's control, such as a move out of state or a change in insurance, and whether those departures count against the earnout threshold. Buyers should negotiate quarterly reporting rights and an independent audit option if the parties dispute the measurement.
Yes, behavioral health practices are SBA-eligible businesses, and SBA 7(a) loans are one of the most common financing tools for individual buyers acquiring outpatient therapy and group practices in the $1M–$3M revenue range. The most common barriers to SBA approval in behavioral health are owner-clinician revenue concentration, Medicaid revenue concentration, and HIPAA or billing compliance issues. SBA lenders typically want to see that no single provider — including the selling owner — accounts for more than 30–35% of total collections, because revenue tied to a departing clinician is treated as a key-person risk that threatens loan repayment. Heavy Medicaid reliance, particularly above 40–50% of payer mix, is also viewed as a reimbursement risk due to rate cut exposure. Buyers should address these issues during the pre-LOI period by working with the seller to redistribute patient load and by selecting an SBA lender with demonstrated experience in behavioral health acquisitions, as lender familiarity with the industry significantly accelerates underwriting.
This is one of the most consequential operational risks in any behavioral health acquisition, and how it is handled depends heavily on the deal structure. In a stock purchase, the existing payer contracts typically transfer with the entity because the legal entity does not change — only the ownership changes. However, most insurance contracts include change-of-control notification requirements, and some require prior written consent from the payer before closing. In an asset purchase, payer contracts are generally not transferable and must be re-contracted or re-credentialed under the new entity, a process that typically takes 90–180 days and during which the practice may not be able to bill those payers for services rendered. Experienced buyers initiate the re-credentialing process at the LOI stage and negotiate a transition services agreement with the seller allowing the seller's provider NPI numbers to be used for billing during the credentialing gap. This is one of the strongest arguments for using a stock purchase structure when it is legally available, as it eliminates or significantly reduces credentialing disruption.
Mitigating key-person risk is the central challenge in behavioral health practice acquisitions where the seller is also the primary clinician. Buyers use several layered mechanisms to address this. First, the seller's employment or consulting agreement — typically 12–24 months post-close — keeps the owner-clinician present, visible, and actively engaged in patient care and referral relationship management during the transition. Second, earnout structures tie a meaningful portion of the purchase price to patient census retention, giving the seller a direct financial incentive to retain patients rather than passively allow attrition. Third, buyers negotiate non-solicitation agreements preventing the seller from opening a competing practice or contacting former patients or referral sources within a defined radius and time period, typically 25 miles and 3 years. Fourth, proactive clinical communication — a patient letter introducing the new owner and emphasizing continuity of care — is timed at closing to minimize uncertainty. Practices with diversified clinician rosters where the owner provides less than 25% of total services command higher multiples precisely because they have already structurally reduced this risk.
Behavioral health practices in the lower middle market typically trade at 3.5x–6x EBITDA, with the wide range reflecting the significant variation in quality, risk, and scalability between practices. Practices that trade at the upper end of the range — 5x–6x EBITDA — share several characteristics: revenue is diversified across 10 or more licensed clinicians with no single provider above 25% of collections, the payer mix includes established commercial insurance contracts with Medicare and Medicaid credentialing, the practice has a documented MSO structure separating management from clinical operations, EBITDA margins are 20–25%, and the EHR and billing systems are clean and auditable. Practices that trade at the lower end — 3.5x–4.5x — typically have significant owner-clinician revenue concentration, heavy Medicaid reliance, undocumented or cash-basis revenue, or outstanding compliance issues. Adding a second service line such as an IOP program or telehealth platform, establishing a documented referral pipeline from schools or primary care physicians, and implementing clinician retention agreements can meaningfully move a practice from the lower to the upper end of the multiple range before going to market.
More Behavioral Health Practice Guides
More Deal Structure Guides
Find the right target, structure the deal, and close with confidence.
Create your free accountNo credit card required
For Buyers
For Sellers